Calamos Wealth Management LLC Abbott Laboratories Transaction History

Calamos Wealth Management LLC

$1.89 Billion
Q3 2024

A detailed history of Calamos Wealth Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Calamos Wealth Management LLC holds 8,902 shares of ABT stock, worth $1.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,902

Previous 8,826 0.86%

Holding current value

$1.02 Million

Previous $917,000 10.58%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $7,605 - $8,977	76 Added 0.86%	8,902 $1.01 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $5,842 - $6,521	58 Added 0.66%	8,826 $917,000
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $21,684 - $23,950	-198 Reduced 2.21%	8,768 $996,000
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $121,666 - $148,929	-1,349 Reduced 13.08%	8,966 $986,000
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $72,889 - $87,455	763 Added 7.99%	10,315 $999,000
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $79,313 - $88,372	-787 Reduced 7.61%	9,552 $1.04 Million
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $9,686 - $11,401	-100 Reduced 0.96%	10,339 $1.05 Million
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $11,407 - $13,382	-120 Reduced 1.14%	10,439 $0
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $9,095 - $10,530	-94 Reduced 0.88%	10,559 $1.02 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $41,644 - $50,334	-408 Reduced 3.69%	10,653 $1.16 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $23,944 - $29,198	-210 Reduced 1.86%	11,061 $1.31 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $11,668 - $14,287	101 Added 0.9%	11,271 $1.59 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $463,023 - $512,239	3,969 Added 55.12%	11,170 $1.32 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $123,245 - $145,077	1,165 Added 19.3%	7,201 $835,000
Q1 2021 Apr 12, 2021	BUY	$108.84 - $128.23 $37,876 - $44,624	348 Added 6.12%	6,036 $723,000
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $104,790 - $114,191	998 Added 21.28%	5,688 $623,000
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $194,276 - $235,934	2,120 Added 82.49%	4,690 $510,000
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $120,214 - $153,860	-1,570 Reduced 37.92%	2,570 $235,000
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $41,335 - $60,443	-658 Reduced 13.71%	4,140 $327,000
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $22,061 - $24,559	281 Added 6.22%	4,798 $417,000
Q3 2019 Oct 21, 2019	BUY	$81.84 - $88.74 $106,146 - $115,095	1,297 Added 40.28%	4,517 $378,000
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $234,673 - $273,700	3,220 New	3,220 $271,000
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $601,709 - $681,650	-9,178 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$57.57 - $63.54 $25,618 - $28,275	445 Added 5.1%	9,178 $560,000
Q1 2018 Apr 13, 2018	BUY	$56.27 - $63.62 $491,405 - $555,593	8,733 New	8,733 $524,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Abbott Laboratories Transaction History